Yazji Salim

Chief Medical OfficerOncternal Therapeutics, Inc. (ONCT) · full profile →Form 4 · filed Oct 4, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
0 non-derivative · 9 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 2, 2023Disposed to issuer(D)354K0
Oct 2, 2023Disposed to issuer(D)92K0
Oct 2, 2023Disposed to issuer(D)55K0
Oct 2, 2023Disposed to issuer(D)210K0
Oct 2, 2023Grant(A)71K$071K
Oct 2, 2023Grant(A)92K92K
Oct 2, 2023Grant(A)55K55K
Oct 2, 2023Grant(A)210K210K
Oct 2, 2023Grant(A)354K354K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-052022) within minutes of acceptance. Every field above traces to the original document. Verify it directly: